| Value | ₹3,350 Cr |
|---|
NSE filing, NSE: GUJTHEM. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Themis Biosyn Ltd: key numbers
- Share price
- ₹391.50
- Market cap
- ₹5,095 Cr
- Revenue (annual)
- ₹165.8 Cr
- Net profit (annual)
- ₹46.68 Cr
- P/E (TTM)
- 104.7×Sector 41.3×
- Promoter holding
- 59.33%-11.53% QoQ
- FII holding
- 3.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Themis Biosyn Ltd
All →Gujarat Themis Biosyn Board Meeting Date
Gujarat Themis Biosyn scheduled its board meeting for 4 Nov 2026 to approve Q2 and H2 un-audited results. No financial figures are disclosed in this advance intimation.
Gujarat Themis Biosyn Other Announcement
Gujarat Themis Biosyn clarified that its 9 October 2026 credit-rating intimation was uploaded in error and should be disregarded. No substantive business event is reported.
Gujarat Themis Biosyn Other Announcement
Gujarat Themis Biosyn Limited submitted the mandatory quarterly compliance certificate under SEBI Regulation 74(5) regarding dematerialization of shares for the quarter ended September 30, 2026.
Gujarat Themis Biosyn Annual General Meeting
Gujarat Themis Biosyn Ltd held its 45th Annual General Meeting on September 30, 2026, to deliberate on ordinary and special business resolutions.
Gujarat Themis Biosyn Annual General Meeting
Gujarat Themis Biosyn issued a corrigendum to its 45th AGM notice, updating the preferential issue resolution regarding share price, issue size, and allottee details.
Gujarat Themis Biosyn Acquisition Worth ₹1,300 Cr
Gujarat Themis Biosyn Limited acquired MicroBiopharm Japan Co. Ltd. for approximately ₹1,300 Crore. This acquisition expands its pharmaceutical CDMO capabilities.
- Value
- ₹1,300 Cr
Other preferential issue announcements
All →5Paisa Capital Preferential Issue
5paisa allotted 20,50,588 preferential equity shares at ₹380 each for Giskard Datatech shares. The allotment aggregates ₹77.92 Crore, paid via share swap.
- Value
- ₹77.92 Cr
Stellant Securities (India) Preferential Issue
Stellant Securities allotted 678,388 equity shares and 166,200 warrants on a preferential basis at Rs 602 each. Total cash consideration is about Rs 50.84 Cr, with 25% received on the warrants.
- Value
- ₹50.84 Cr
Balaji Phosphates Preferential Issue
Balaji Phosphates filed a revised valuation report for in-principle approval of its equity shares and convertible warrants issue. The filing responds to an NSE letter dated November 4, 2026, with no amount stated.
Rossell Techsys Preferential Issue
Rossell Techsys allotted 25,72,898 preferential shares to SBI funds for Rs.299.99 Crore. The allotment is at Rs.1,166 per share with two allottees.
- Value
- ₹300.0 Cr
Datakosa Preferential Issue
Datakosa received BSE listing approval for 20,58,822 equity shares issued on a preferential basis to non-promoters at ₹17 per share. The approval is a post-allotment listing step in a preferential issue.
- Value
- ₹3.50 Cr
Jetking Infotrain Preferential Issue
Jetking Infotrain withdrew its proposed ₹11.50 Crore preferential issue due to prevailing market conditions. It also withdrew the pending BSE in-principle listing application.
- Value
- ₹11.50 Cr